Annals ofMultiple Sclerosis

Volume: 2 - Number: 12 - December 15, 2005

Seguimos creciendo para Brindar el mejor servicio

Debate and Education

Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis

Editorial

Infection as a cause of multiple sclerosis

Patients at Risk

Selective Adhesion-Molecule Therapy and Inflammatory Bowel Disease — A Tale of Janus?

Seguimos creciendo para Brindar el mejor servicio

Investigational Article

IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis

Control of homeostatic proliferation by regulatory T cells

Letters

Rehabilitation services remain important in multiple sclerosis

Seguimos creciendo para Brindar el mejor servicio

News

Epstein-Barr virus may increase risk of multiple sclerosis

Netherlands to run trials of marijuana in patients with multiple sclerosis

Original Articles

Brief Report:Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis

Brief Report:Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab

Brief Report:Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

Seguimos creciendo para Brindar el mejor servicio

Papers

Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis • Commentary: Evaluating disease modifying treatments in multiple sclerosis

Perspective

Medical Marijuana and the Supreme Court

Review Articles

Mechanisms of Disease: Calpains and Disease

Mechanisms of Disease: Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs

Seguimos creciendo para Brindar el mejor servicio

Buscador

Copyright © Dr. Mario I. Cámera .:. Powered by ForamenAlojado en ...